Response to Letter to the Editor: IRF8 is a Reliable Monoblast Marker for Acute Monocytic Leukemias but does not Discriminate Between Monoblasts and Plasmacytoid Dendritic Cells : The American Journal of Surgical Pathology

Secondary Logo

Journal Logo

You can read the full text of this article if you:

Access through Ovid
Letter to the Editor

Response to Letter to the Editor: IRF8 is a Reliable Monoblast Marker for Acute Monocytic Leukemias but does not Discriminate Between Monoblasts and Plasmacytoid Dendritic Cells

Xu, Mina L. MD; Katz, Samuel G. MD, PhD

Author Information
The American Journal of Surgical Pathology: December 2022 - Volume 46 - Issue 12 - p 1739
doi: 10.1097/PAS.0000000000001961
  • Buy
Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.